Florida Cancer Specialists & Research Institute Welcomes Medical Oncologist Dr. Nikhita Kathuria-Prakash

Strategic Insights -

Noted medical oncologist and hematologist Dr. Nikhita Kathuria-Prakash has joined Florida Cancer Specialists & Research Institute's statewide practice, bringing with her a commitment to excellence in clinical care, research, and medical education. As an assistant managing physician notes, Dr. Kathuria-Prakash's dedication to improving oncology care delivery and community outreach will enrich the lives of patients and residents in Columbia County. Dr. Kathuria-Prakash's impressive background includes medical school, residency training, and a fellowship in hematology/oncology at the University of California, Los Angeles (UCLA). She has led and contributed to multiple clinical research initiatives and has published and presented her research findings extensively.

Key Takeaways:

  • Dr. Nikhita Kathuria-Prakash has joined Florida Cancer Specialists & Research Institute's statewide practice, bringing extensive experience in medical oncology and hematology.
  • Dr. Kathuria-Prakash completed medical school, residency training, and a fellowship in hematology/oncology at the University of California, Los Angeles (UCLA).
  • She has led and contributed to multiple clinical research initiatives across UCLA and the School of Medicine at the University of California, Irvine.
  • Dr. Kathuria-Prakash has published and presented numerous articles related to her research findings and has extensive experience teaching and mentoring medical students.
  • Her commitment to clinical care, research, and medical education will enrich the lives of patients and residents in Columbia County.
  • Dr. Kathuria-Prakash has a strong background in precision oncology advancements, committed to delivering tailored treatment plans for enhanced patient outcomes.

Statistics:

  • More than 40 years of experience in delivering world-class care through innovation
  • FCS has a robust clinical research program, providing patients with access to a wide range of clinical trials
  • Before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS
  • Florida Cancer Specialists & Research Institute has a dedicated team of highly trained and committed physicians

Sources:

  • PRNewswire
  • Florida Cancer Specialists & Research Institute (FLCancer.com)
  • University of California, Los Angeles (UCLA)